Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

The Canadian Agency for Drugs and Technologies in Health (CADTH) conducted a systematic review to evaluate the clinical, economic and budgetary implications of pulmonary rehabilitation (PR) programs to assist policy-makers and health care providers with future decisions in the establishment and utilization of these programs.

Report

This report has been extensively peer-reviewed by external clinical and methodological experts.

• Technology Report (155 pages)

Summaries

• Report in Brief (1 page: Report-at-a-glance)
• Executive Summary (3 pages)